19/10/2026
The DUPHAT Scientific Advisory Board came together to discuss and shape the conference programme for DUPHAT 2027, bringing together scientific expertise, industry insights, and innovative perspectives to advance pharmaceutical knowledge and practice.
With a focus on scientific excellence, career development, and pharmaceutical industry innovation, the Board will contribute to developing a forward-looking programme that addresses emerging trends, current challenges, and new opportunities across the pharmaceutical sector.
Together, we look forward to creating an impactful platform for knowledge exchange, professional growth, and collaboration across the global pharmaceutical community.
The meeting was headed by H.E. Ambassador Dr. Abdulsalam AlMadani, Roving Ambassador of the Parliamentary Assembly of the Mediterranean (PAM) for the GCC Region; Chairman of DUPHAT in the presence of:
Dr. Farida AlKhaja, Senior Advisor, Pharmacy Services, Dubai Health, Head of DUPHAT Scientific Program, Dr. Younis Kazim, Acting CEO of Health Regulation Sector, Dubai Health Authority, Prof. Peter J. Pitts, Former Member, Sr. Executive Service and Associate Commissioner, US FDA; President of the Center for Medicine in the Public Interest; Mr. Klaus Meier, President, European Society of Oncology Pharmacy (ESOP) Global, Dr. Mariam Galadari, Public Affairs and Board Advisor, Global Pharma, Dr. Janet P. Engle, Executive Director, Accreditation Council for Pharmacy Education (ACPE), Dr. Nadia Al Mazroui, Vice President, International Pharmaceutical Federation (FIP), Associate Professor, University of Sharjah, Dr. Mohamed Nasser Chairman, Pharmaceutical Industry Association in MEA (PHARMEA) Vice President & General Manager of Amgen in the Middle East & Africa (MEA), Members INDEX Media UAE & DUPHAT Executive Office.